Menu

Study documentation (link to documents, only accessible with password to www.nsgo.org).

Click HERE for access.

Study sponsorNSGO
NSGO-CTU Project ManagerMette Engell
NSGO-CTU, Rigshospitalet, Copenhagen, Denmark.
mette.engell@regionh.dk
+45 3545 3389
Study ChairMansoor Raza Mirza
NSGO, Rigshospitalet, Copenhagen, Denmark
mansoor.raza.mirza@regionh.dk
+45 3545 9624
Drug Durvalumab and MEDI9447
Phase II
Randomized trial No
Type Open-label
Total number of patients 25 patients required
Number of patients recruitedRecruitment statistics – link
Trial statusRecruitment closed
Date of first site activatedMarch 2018
eCRFOpen Clinica test – link (protected information – access only with login)
Open Clinica Live –link (protected information – access only with login)
Site listSite list – Not available. Will be added soon.
Protocol summaryClinicalTrials.gov – link

Click HERE for access.